Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
153
天
Oncolytic adenovirus incorporating TetO sites in the E1A promoter for controlled replication in TetR-expressing mesenchymal stem cells
作者
Ramon Alemany; Silvia Torres-Manjon; Laia Traveset; Rafael Moreno展开收起
作者单位
Cancer Immunotherapy Group, Oncobell and IProCURE programs, IDIBELL-Institut Català D'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain; Innovation unit, Business Development and Innovation area, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain展开收起
490
天
Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant
作者
Yeongrin Kim; Da Yeon Lee; Ji U. Choi; Moonjung Jeun; Heung Kyoung Lee; Sang Un Choi; Chi Hoon Park展开收起
作者单位
Data Convergence Drug Research Center, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea; College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea; Medicinal Chemistry and Pharmacology, University of Science and Technology, Daejeon 34113, Republic of Korea展开收起
55
天
Feasibility and outcomes of decentralized point-of-care CD19 CAR T cell for relapsed large B cell lymphoma in resource-limited settings
作者
Koramit Suppipat; Supannikar Tawinwung; Ornnicha Sathitakorn; Chantiya Chanswangphuwana; Kanhatai Chiengthong; Mutita Surakijboworn; Thiti Asawapanumas; Phandee Watanaboonyongcharoen; Palada Pitakkitnukun; Manaschanok Tippawan; Supanat Kumjan; Udomsak Bunworasate; Nattiya Hirankarn; Kitsada Wudhikarn展开收起
作者单位
Center of Excellence in Cellular Immunotherapy, Chulalongkorn University, Bangkok 10330, Thailand; Department of Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand; Division of Hematology and Center of Excellence in Translational Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Center of Excellence in Pediatric Hematology/Oncology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Transfusion Medicine Unit, King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand; Transplant and Cellular Therapy Unit, King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand; Center of Excellence in Immunology and Immune-Mediated Diseases, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand展开收起
159
天
Augmenting CAR T cell functionality and metabolism through CD39 downtuning
作者
Dennis Christoph Harrer; Jeremy Baldwin; Markus Barden; Hong Pan; Bence Gergely; Árpád Szöőr; György Vereb; Wolfgang Herr; Hinrich Abken展开收起
作者单位
Department of Hematology and Internal Oncology, University Hospital Regensburg, 93053 Regensburg, Germany; Leibniz Institute for Immunotherapy, Div. Genetic Immunotherapy, Chair Genetic Immunotherapy, University Regensburg, 93053 Regensburg, Germany; Leibniz Institute for Immunotherapy, Div. Functional Immune Cell Modulation, University Regensburg, 93053 Regensburg, Germany; Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK; Department of Biophysics and Cell Biology, University of Debrecen Faculty of Medicine, 4032 Debrecen, Hungary; University of Debrecen Faculty of Pharmacy, 4032 Debrecen, Hungary展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天